Nanoparticle Based Drug Delivery System: Milestone for Cancer Therapy
Journal Title: Journal of Biomedical and Pharmaceutical Research - Year 2012, Vol 1, Issue 2
Abstract
The challenge of modern drug therapy is the optimization of the pharmacological action of the drugs coupled with the reduction of their toxic effects in vivo. The prime objectives in the design of drug delivery systems (DDS) are the controlled delivery of the drug to its site of action at a therapeutically optimal rate and dosage to avoid toxicity and improve the drug effectiveness and therapeutic index. DDS has improved many of the pharmacological properties of conventional ("free") drugs including particulate carriers which are primarily composed of lipids and/or polymers and their associated therapeutics. It alters the pharmacokinetics (PK) and biodistribution (BD) of the associated drugs or functions as drug reservoir or both. Nanoparticles provide a range of new opportunities to increase the targeting of currently approved diagnostic and therapeutic agents to cancers. Nanoparticles carrying a chemotherapeutic can reduce the undesirable distribution of such agents. The problems related to cancer chemotherapy can partially be overcome by direct intratumoral delivery of controlled release biodegradable nanoparticles (NPs).
Authors and Affiliations
Dr. Gousia Chashoo| Pharmacology Division, Indian Institute of Integrative Medicine, canal road, Jammu., Dr. Shashank K Singh| Pharmacology Division, Indian Institute of Integrative Medicine, canal road, Jammu., Dr. Naveed A Qazi| Medicinal chemistry Division, Indian Institute of Integrative medicine, canal road, Jammu., Dr. Ajit K Saxena| Pharmacology Division, Indian Institute of Integrative Medicine, canal road, Jammu.
Keywords
Related Articles
- EP ID EP1506
- DOI -
- Views 577
- Downloads 29
“A Large Incidentally-Diagnosed Left-Lobed Hepatic Hydatid Cyst in a Young Male Patient”
Introduction: Despite modern healthcare facilities, hydatid disease (HD) remains a perpetuating public health problem in endemic countries. Infection with Echinococcus may have a diverse clinical evolution, leading even...
COMPARISON BETWEEN COBAS E411 AND ICT IN DIAGNOSIS OF HEPATITIS B VIRUS
Background: Hepatitis B is one of the world’s most common and serious infectious diseases. It is estimated that more than one third of the world’s population has been infected with hepatitis B virus Differentiation betwe...
RELATION OF ANTIOXIDANT STATUS AND LIPOPROTEIN (a) LEVEL IN MYOCARDIAL INFARCTION PATIENTS : A CLINICAL STUDY TO EVALUATE THE ANTIOXIDANT/ LIPOPROTEIN (a) RATIO AS A NOVEL PARAMETER TO INDICATE CARDIOVASCULAR ACCIDENT
Lipoprotein (a), a prominent marker of cardiovascular accident, was first described by Berg in 1963(3). Lipoprotein (a) [Lp(a)] has been considered as one of the distinguished signature in myocardial infarction and for m...
UTILIZATION PATTERN AND MEDICATION ADHERENCE OF ORAL ANTI-DIABETIC MEDICATIONS AMONG TYPE 2 DIABETES MELLITUS PATIENTS IN RURAL AREAS OF KARNATAKA, SOUTH INDIA.
Objective: To assess the utilization pattern and medication Adherence of oral anti-diabetic medications among patients with type 2 diabetes mellitus in rural areas of Bangalore East. Methodology: A prospective observatio...
PRELIMINARY SCREENING OF SECONDARY METABOLITES AND BRINE SHRIMP LETHALITY BIOASSAY OF WARM-WATER EXTRACT OF PUFFER FISH ORGANS TISSUES, TETRAODON CUTCUTIA, AVAILABLE IN BANGLADESH.
This study is aimed to establish the invitro screening of secondary metabolites namely alkaloids, steroids, alcoholic compounds, glycosides, and amide group containing compounds from warm-water extracts of puffer fish d...